Alzheimer’s disease drug-development pipeline: few candidates, frequent failures

INTRODUCTION: Alzheimer’s disease (AD) is increasing in frequency as the global population ages. Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist. We have an urgent need to find new therapies for AD. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Cummings, Jeffrey L, Morstorf, Travis, Zhong, Kate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095696/
https://www.ncbi.nlm.nih.gov/pubmed/25024750
http://dx.doi.org/10.1186/alzrt269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095696/
https://www.ncbi.nlm.nih.gov/pubmed/25024750
http://dx.doi.org/10.1186/alzrt269

Ejemplares similares